VmCT1-NH2
General Information
DRACP ID DRACP02277
Peptide Name VmCT1-NH2
Sequence FLGALWNVAKSVF
Sequence Length 13
UniProt ID I0DEB3
PubChem CID Not available
Origin Vaejovis mexicanus smithi
Type Native peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | 12.5 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: ~0% Hemolytic=6.3 µM
Normal (non-cancerous) Cytotoxicity MCF-10A: Not active up to 25 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C72H106N16O16
Absent amino acids CDEHIMPQRTY
Common amino acids AFLV
Mass 166596
Pl 9.7
Basic residues 1
Acidic residues 0
Hydrophobic residues 9
Net charge 1
Boman Index 1518
Hydrophobicity 120.77
Aliphatic Index 120
Half Life
Mammalian: 1 hour
Yeast: 2 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 458.33
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31181304
Title The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1
Doi 10.1016/j.ejps.2019.06.006
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPR_3475